David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
851
DELISTED
Paramount Global Class B
PARA
| $12M | 0.02% |
854,591
+804,749
| +1,615% | +$23.1M |
|
852
Inogen
INGN
$146M
| $12M | 0.02% |
231,470
-133,193
| -37% | -$6.4M |
|
853
Brunswick
BC
$5.26B
| $11.9M | 0.02% |
337,570
-265,812
| -44% | -$14.1M |
|
854
Genworth Financial
GNW
$3.74B
| $11.9M | 0.02% |
3,594,055
+2,968,447
| +474% | +$12.3M |
|
855
Churchill Downs
CHDN
$6.32B
| $11.9M | 0.02% |
231,348
+157,328
| +213% | +$10.1M |
|
856
Exelixis
EXEL
$13.5B
| $11.9M | 0.02% |
690,097
-622,535
| -47% | -$11.4M |
|
857
Guidewire Software
GWRE
$16B
| $11.9M | 0.02% |
149,705
+143,390
| +2,271% | +$15M |
|
|
SAGE
858
DELISTED
Sage Therapeutics
SAGE
| $11.9M | 0.02% |
413,230
+336,537
| +439% | +$19.5M |
|
|
ALXN
859
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $11.8M | 0.02% |
131,900
+46,300
| +54% | +$4.54M |
|
860
News Corp Class A
NWSA
$16.6B
| $11.8M | 0.02% |
1,318,537
-302,787
| -19% | -$3.82M |
|
861
BlackBerry
BB
$4.48B
| $11.8M | 0.02% |
2,861,457
-93,978
| -3% | -$511K |
|
862
M&T Bank
MTB
$34.9B
| $11.8M | 0.02% |
114,104
-54,396
| -32% | -$8M |
|
863
CenterPoint Energy
CNP
$25.8B
| $11.8M | 0.02% |
762,783
+752,683
| +7,452% | +$17.3M |
|
864
CALL
Western Digital
WDC
$157B
| $11.8M | 0.02% |
374,277
+99,225
| +36% | +$4.39M |
|
865
PUT
CoStar Group
CSGP
$13.3B
| $11.7M | 0.02% |
+200,000
| New | +$13M |
|
866
CRISPR Therapeutics
CRSP
$5.52B
| $11.7M | 0.02% |
275,859
+267,192
| +3,083% | +$13.8M |
|
867
Bio-Techne
TECH
$11.3B
| $11.7M | 0.02% |
246,568
-59,208
| -19% | -$2.96M |
|
868
Amcor
AMCR
$22.2B
| $11.7M | 0.02% |
287,190
+160,282
| +126% | +$7.68M |
|
869
CALL
Hershey
HSY
$38.2B
| $11.6M | 0.02% |
87,900
-31,900
| -27% | -$4.71M |
|
870
HNI Corp
HNI
$3.54B
| $11.6M | 0.02% |
461,392
+32,209
| +8% | +$1.07M |
|
871
Sabra Healthcare REIT
SBRA
$5.23B
| $11.5M | 0.02% |
1,056,330
+987,068
| +1,425% | +$18.2M |
|
|
SPLK
872
PUT
DELISTED
Splunk Inc
SPLK
| $11.5M | 0.02% |
91,300
-30,800
| -25% | -$4.53M |
|
873
AptarGroup
ATR
$8.57B
| $11.5M | 0.02% |
115,523
+48,669
| +73% | +$5.28M |
|
874
PUT
Illumina
ILMN
$33.7B
| $11.5M | 0.02% |
43,279
+13,673
| +46% | +$3.82M |
|
875
Encompass Health
EHC
$11.9B
| $11.5M | 0.02% |
225,187
-236,931
| -51% | -$13.7M |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.